Earnings call Monash IVF reported H1 FY25 revenue growth of 12% YoY and underlying NPAT of $15.8M, up 5.5%, in line with guidance. EBITDA rose 10.7% to $35.6M with stable 25% margins. FY25 NPAT ...
Earnings call H1 FY26 revenue declined 1.8% YoY to AUD 137.9m, with underlying NPAT of AUD 10.4m at the upper end of guidance and EBITDA margin at 22% (down 3.5pp). Management reaffirmed FY26 NPAT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results